Patent details

EP3773498 Title: LIQUID PHARMACEUTICAL FORMULATION

Basic Information

Publication number:
EP3773498
PCT Application Number:
EP2019057984
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197194285
PCT Publication Number:
WO2019185859
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LIQUID PHARMACEUTICAL FORMULATION
French Title of Invention:
FORMULATION PHARMACEUTIQUE LIQUIDE
German Title of Invention:
FLÜSSIGE PHARMAZEUTISCHE FORMULIERUNG
SPC Number:

Dates

Filing date:
29/03/2019
Grant date:
22/06/2022
EP Publication Date:
17/02/2021
PCT Publication Date:
03/10/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/06/2022
EP B1 Publication Date:
22/06/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/03/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/06/2022
 
 

Name:
Project Pharmaceutics GmbH
Address:
Fraunhoferstrasse 22, 82152 Martinsried, Germany (DE)

Agent

Name:
SCHIWECK WEINZIERL KOCH
From:
20/09/2022
Address:
Ganghoferstr. 68B, 80339, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
SCHUETZ, Andreas
Address:
Germany (DE)

2

Name:
HELLERBRAND, Klaus
Address:
Germany (DE)

Priority

Priority Number:
100750
Priority Date:
29/03/2018
Priority Country:
Luxembourg (LU)

Classification

IPC classification:
A61K 9/08; A61K 47/02; A61K 47/10; A61K 31/4184; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202225
Publication date:
22/06/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
20/03/2025
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages
20/09/2022 Power Of Attorney 1
22/09/2022 Outgoing Correspondence 1